Erasca, Inc. (ERAS)

17.04 +1.56 (+10.08%) USD  |  NASDAQ  |  Nov 11, 13:35
More

Erasca Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for ERAS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Immunome, Inc. Upgrade
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. Upgrade